Acne and rosacea: New and emerging therapies

Dermatologic Clinics

Volumn 18, Issue 1, 2000, Pages 63-71

  Thiboutot, Diane M ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANTIBIOTIC AGENT; ETHINYLESTRADIOL PLUS NORGESTIMATE; ISOTRETINOIN; METRONIDAZOLE; MINOCYCLINE; ORAL CONTRACEPTIVE AGENT; RETINOIC ACID; RETINOID; RETINOL; TAZAROTENE; TETRACYCLINE;

ACNE; BRAIN PSEUDOTUMOR; DRUG INDUCED DISEASE; HELICOBACTER PYLORI; HORMONAL THERAPY; HUMAN; PRIORITY JOURNAL; REVIEW; ROSACEA; SKIN DISEASE; TREATMENT INDICATION;

EID: 0033962534     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70147-9     Document Type: Article

References (33)

1. D. Breneman D. Stewart O. Hevia A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1% cream to vehicle in patients with rosacea Cutis 1998 6144 6147
2. A. Chiu W. Chuenkongkaew W. Cornblath Minocycline treatment and pseudotumor cerebri syndrome Am J Ophthalmol 1998 126116 126121
3. W. Cunliffe R. Caputo B. Dreno Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris J Am Acad Dermatol 36S 1997 126 134
4. Cunliffe W. van de Kerkhof P. R. Caputo Roaccutane treatment guidelines: Results of an international survey Dermatology 194 1997 351 357
5. M. Dahl H. Katz G. Krueger Topical metronidazole maintains remissions of rosacea Arch Dermatol 134 1998 679 683
6. F. Dunlap O. Mills M. Tuley Adapalene 0.1% gel for the treatment of acne vulgaris: Its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference Br J Dermatol 139 suppl 52 1998 17 22
7. C. Ellis L. Millikan E. Smith Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris Br J Dermatol 139 suppl 52 1998 41 47
8. K. Embil S. Nacht The microsponge delivery system (MDS): A topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives J Microencapsul 13 1996 575 588
9. F. Erdogan Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea Arch Dermatol 134 1998 884 885
10. FDA orders new Accutane warning label Dermatology World 8 1998 6
11. J. Gibson Rationale for the development of new topical treatments for acne vulgaris Cutis 57 1996 13 19
12. V. Goulden S. Clark C. McGeown Treatment of acne with intermittent isotretinoin Br J Dermatol 137 1997 106 108
13. R. Guy M. Green T. Kealey Modeling of acne in vitro J Invest Dermatol 106 1996 176 182
14. M. Jones Helicobacter pylori in rosacea: Lack of an association Arch Dermatol 134 1998 511
15. J. Jorizzo M. Lebwohl R. Tobey The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: A double-blind clinical trial J Am Acad Dermatol 1998 39502 39504
16. A. Kindmark O. Rollman H. Mallmin Oral isotretinoin therapy in severe acne induces transient suppression of biochemical markers of bone turnover and calcium homeostasis Acta Derm Venereol 78 1998 266 269
17. L. Lamberg Acne drug depression warnings highlight need for expert care JAMA 810 1998 57
18. J. Leyden Topical treatment of acne vulgaris: Retinoids and cutaneous irritation J Am Acad Dermatol 38 1998 S1 S4
19. A. Lucky S. Cullen T. Funicella Double-blind, vehicle-controlled, multicenter comparison of two 0.025% tretinoin creams in patients with acne vulgaris J Am Acad Dermatol 38 1998 S24 S30
20. A. Lucky S. Cullen M. Jarratt Comparative efficacy and safety of two 0.025% tretinoin gels: Results from a multicenter, double-blind, parallel study J Am Acad Dermatol 38 1998 S17 S23
21. A. Lucky T. Henderson W. Olson Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris J Am Acad Dermatol 37 1997 746 754
22. S. Maddin FDA warning about isotretinoin Skin Therapy Letter 3 1998 3 5
23. D. Margolis M. Attie J. Leyden Effects of isotretinoin on bone mineralization during routine therapy with isotretinoin for acne vulgaris Arch Dermatol 132 1996 769 774
24. O. Mills R. Berger Irritation potential of a new topical tretinoin formulation and a commercially-available tretinoin formulation as measured by patch testing in human subjects J Am Acad Dermatol 38 1998 S11 S16
25. S. Niemec H. Wu S. Jayaraman Effect of polyolprepolymer on the disposition of retinoic acid in various strata of hamster ear following application of gel formulations: Correlation with disposition in human skin Drug Delivery 1997 433 436
26. G.P. Redmond W.H. Olson J.S. Lippman Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trial Obstet Gynecol 89 1997 615 622
27. D. Seukeran W. Cunliffe Acne vulgaris in the elderly: The response to low-dose isotretinoin Br J Dermatol 139 1998 99 101
28. A. Shalita J. Weiss D. Chalker A comparison of the efficacy and safety of adapalene gel 0.01% and tretinoin gel 0.025% in the treatment of acne vulgaris: A multicenter trial J Am Acad Dermatol 34 1996 482 485
29. V. Sharma A. Lynn M. Kaminski A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea Am J Gastroenterol 93 1998 220 222
30. D. Thiboutot G. Harris V. Iles Activity of the type 1 5α-reductase exhibits regional differences in isolated sebaceous glands and whole skin J Invest Dermatol 105 1995 209 214
31. D. Thiboutot H. Knaggs K. Gilliland Activity of the type 1 5a-reductase is greater in keratinocytes cultures from the follicular infrainfundibulum compared to the interfollicular epidermis J Invest Dermatol 106 1996 866
32. M. Verschoore M. Poncet J. Czernielewski Adapalene 0.1% gel has low skin irritation potential J Am Acad Dermatol 36 1997 S104 S109
33. G. Webster Topical tretinoin in acne therapy J Am Acad Dermatol 39 1998 S38 S44